{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:29:18Z","timestamp":1793683758789,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjmed.2026.08.030","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:19:20Z","timestamp":1789665560000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated steatotic liver disease and outcomes in atrial fibrillation"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-165X","authenticated-orcid":false,"given":"Pojsakorn","family":"Danpanichkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwanjit","family":"Duangsonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithila","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primrose","family":"Tothanarungroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Anouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Y.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Liangpunsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2026.08.030_bib0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3350\/cmh.2024.0631","article-title":"Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations","volume":"31","author":"Danpanichkul","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0002","first-page":"0","article-title":"Global epidemiological patterns and disease burden of MASLD, MetALD, and ALD","author":"Danpanichkul","year":"2026","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2468-1253(26)00011-7","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 1990\u20132023, and projections to 2050: a systematic analysis for the global burden of disease study 2023","volume":"11","author":"Kim","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0004","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.3350\/cmh.2025.0802","article-title":"Contemporary trends in extrahepatic mortality of chronic liver disease in the United States from 2014 to 2023","volume":"32","author":"Kim","year":"2026","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMcp2023658","article-title":"Atrial fibrillation","volume":"384","author":"Michaud","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120495","article-title":"Understanding MASLD - from molecular pathogenesis to cardiovascular risk: a concise review for the clinical cardiologist","volume":"409","author":"Ratti","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0008","article-title":"A systematic review and meta-analysis of cohort studies on the potential association between NAFLD\/MAFLD and risk of incident atrial fibrillation","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0009","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0010","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/liv.14044","article-title":"Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis","volume":"39","author":"Mantovani","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0011","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70575","article-title":"Liver, cardiovascular and infectious outcomes in alcohol-associated liver disease with cardiometabolic risk factors","volume":"46","author":"Danpanichkul","year":"2026","journal-title":"Liver Int"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/HEP.0000000000001333","article-title":"Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: target trial emulation using real-world data","volume":"83","author":"Ng","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0014","unstructured":"TriNetX. Data from: TriNetX research network database 2022."},{"key":"10.1016\/j.amjmed.2026.08.030_bib0015","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3350\/cmh.2024.0157","article-title":"Changing from NAFLD to MASLD: prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia","volume":"30","author":"Suzuki","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0018","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jacc.2020.02.025","article-title":"Atrial fibrillation: JACC council perspectives","volume":"75","author":"Chung","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0019","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","article-title":"Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review","volume":"79","author":"Volgman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0022","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology\/american heart association task force on practice guidelines and the heart rhythm society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0023","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0024","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","article-title":"Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"50","author":"Wijarnpreecha","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial fibrillation: a review","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0027","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2025.08.100","article-title":"The basics of metabolic dysfunction-associated steatotic liver disease for cardiologists: pathophysiology, diagnosis, and treatment","volume":"86","author":"Khan","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0028","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1093\/eurheartj\/ehad592","article-title":"Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications","volume":"44","author":"Naser","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0029","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41569-026-01257-z","article-title":"HFpEF and MASLD: converging mechanisms and clinical implications","volume":"23","author":"Capone","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/HEP.0000000000000735","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","volume":"82","author":"Driessen","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0031","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","article-title":"Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar","volume":"75","author":"Diener","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0032","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jacc.2023.06.029","article-title":"Ablation to reduce atrial fibrillation burden and improve outcomes: JACC review topic of the week","volume":"82","author":"Schwennesen","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0034","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0036","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.jacc.2022.02.010","article-title":"Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes: JACC focus seminar 4\/7","volume":"79","author":"Regensteiner","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0037","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/dom.70545","volume":"28","author":"Chen","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2023.11.012","article-title":"Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Mellemkjaer","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.31726","article-title":"Administrative coding in electronic health care record-based research of NAFLD: An expert panel consensus statement","volume":"74","author":"Hagstrom","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0041","first-page":"672","article-title":"Noninvasive assessment to identify patients with at-risk metabolic dysfunction-associated steatohepatitis","volume":"20","author":"Kalligeros","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0042","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2026.0249","article-title":"Burden of cardiovascular complications in steatotic liver disease in the united states","author":"Kim","year":"2026","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0043","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the american heart association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0044","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"Evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/00015385.2024.2346872","article-title":"The burden of alcohol-related cardiovascular complications in young and middle-aged adults: rising burden of atrial fibrillation and hypertensive heart disease","volume":"79","author":"Danpanichkul","year":"2024","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0046","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.amjmed.2026.08.030_bib0047","article-title":"The global epidemiology of alcohol-associated liver disease","volume":"10","author":"D\u00edaz","year":"2026","journal-title":"Hepatol Commun"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:16:11Z","timestamp":1793682971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326006674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0002934326006674"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.08.030","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction-associated steatotic liver disease and outcomes in atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}